ABT vs. BDX
Compare and contrast key facts about Abbott Laboratories (ABT) and Becton, Dickinson and Company (BDX).
Performance
ABT vs. BDX - Performance Comparison
Loading graphics...
ABT vs. BDX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ABT Abbott Laboratories | -17.64% | 12.87% | 4.81% | 2.26% | -20.68% | 30.53% | 28.04% | 22.08% | 29.06% | 52.03% |
BDX Becton, Dickinson and Company | 3.71% | -12.61% | -5.38% | -2.67% | 5.08% | 1.88% | -6.75% | 22.20% | 6.61% | 31.24% |
Fundamentals
ABT:
$179.36B
BDX:
$44.82B
ABT:
$3.73
BDX:
$6.12
ABT:
27.52
BDX:
25.68
ABT:
4.05
BDX:
2.06
ABT:
3.44
BDX:
1.32
ABT:
$44.33B
BDX:
$21.92B
ABT:
$24.61B
BDX:
$10.03B
ABT:
$11.33B
BDX:
$5.10B
Returns By Period
In the year-to-date period, ABT achieves a -17.64% return, which is significantly lower than BDX's 3.71% return. Over the past 10 years, ABT has outperformed BDX with an annualized return of 11.37%, while BDX has yielded a comparatively lower 4.52% annualized return.
ABT
- 1D
- 0.78%
- 1M
- -11.76%
- YTD
- -17.64%
- 6M
- -22.62%
- 1Y
- -21.15%
- 3Y*
- 2.45%
- 5Y*
- -1.11%
- 10Y*
- 11.37%
BDX
- 1D
- 1.64%
- 1M
- -10.34%
- YTD
- 3.71%
- 6M
- 8.12%
- 1Y
- -10.64%
- 3Y*
- -5.12%
- 5Y*
- -1.60%
- 10Y*
- 4.52%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ABT vs. BDX — Risk / Return Rank
ABT
BDX
ABT vs. BDX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Abbott Laboratories (ABT) and Becton, Dickinson and Company (BDX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ABT | BDX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.92 | -0.34 | -0.58 |
Sortino ratioReturn per unit of downside risk | -1.12 | -0.26 | -0.87 |
Omega ratioGain probability vs. loss probability | 0.84 | 0.96 | -0.12 |
Calmar ratioReturn relative to maximum drawdown | -0.80 | -0.36 | -0.44 |
Martin ratioReturn relative to average drawdown | -2.02 | -0.59 | -1.43 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| ABT | BDX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.92 | -0.34 | -0.58 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.05 | -0.07 | +0.02 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.48 | 0.19 | +0.29 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.41 | 0.43 | -0.02 |
Correlation
The correlation between ABT and BDX is 0.42, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
ABT vs. BDX - Dividend Comparison
ABT's dividend yield for the trailing twelve months is around 2.34%, more than BDX's 2.23% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABT Abbott Laboratories | 2.34% | 1.88% | 1.95% | 1.85% | 1.71% | 1.28% | 1.32% | 1.47% | 1.55% | 1.86% | 2.71% | 2.14% |
BDX Becton, Dickinson and Company | 2.23% | 2.15% | 1.71% | 1.51% | 1.38% | 1.34% | 1.28% | 1.14% | 1.34% | 1.37% | 1.64% | 1.60% |
Drawdowns
ABT vs. BDX - Drawdown Comparison
The maximum ABT drawdown since its inception was -55.57%, which is greater than BDX's maximum drawdown of -51.17%. Use the drawdown chart below to compare losses from any high point for ABT and BDX.
Loading graphics...
Drawdown Indicators
| ABT | BDX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -55.57% | -51.17% | -4.40% |
Max Drawdown (1Y)Largest decline over 1 year | -25.18% | -27.06% | +1.88% |
Max Drawdown (5Y)Largest decline over 5 years | -33.88% | -40.06% | +6.18% |
Max Drawdown (10Y)Largest decline over 10 years | -33.88% | -40.06% | +6.18% |
Current DrawdownCurrent decline from peak | -25.41% | -25.71% | +0.30% |
Average DrawdownAverage peak-to-trough decline | -14.29% | -11.49% | -2.80% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.94% | 16.97% | -7.03% |
Volatility
ABT vs. BDX - Volatility Comparison
Abbott Laboratories (ABT) has a higher volatility of 5.95% compared to Becton, Dickinson and Company (BDX) at 5.44%. This indicates that ABT's price experiences larger fluctuations and is considered to be riskier than BDX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| ABT | BDX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.95% | 5.44% | +0.51% |
Volatility (6M)Calculated over the trailing 6-month period | 16.83% | 16.59% | +0.24% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.14% | 31.36% | -8.22% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.98% | 22.98% | -1.00% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.57% | 23.35% | +0.22% |
Financials
ABT vs. BDX - Financials Comparison
This section allows you to compare key financial metrics between Abbott Laboratories and Becton, Dickinson and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ABT vs. BDX - Profitability Comparison
ABT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Abbott Laboratories reported a gross profit of 6.54B and revenue of 11.46B. Therefore, the gross margin over that period was 57.1%.
BDX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Becton, Dickinson and Company reported a gross profit of 2.34B and revenue of 5.25B. Therefore, the gross margin over that period was 44.6%.
ABT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Abbott Laboratories reported an operating income of 2.25B and revenue of 11.46B, resulting in an operating margin of 19.6%.
BDX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Becton, Dickinson and Company reported an operating income of 594.00M and revenue of 5.25B, resulting in an operating margin of 11.3%.
ABT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Abbott Laboratories reported a net income of 1.78B and revenue of 11.46B, resulting in a net margin of 15.5%.
BDX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Becton, Dickinson and Company reported a net income of 382.00M and revenue of 5.25B, resulting in a net margin of 7.3%.